Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.001 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.002 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |